Form 8-K Theriva Biologics, Inc. For: Jun 11
http://archive.fast-edgar.com/20260611/AKB4222C8Z22UTZ222ZH2ZZZBCBFZ2T2N286
Filed on: June 11, 2026
Form 8-K Enliven Therapeutics, For: Jun 11
false 0001672619 0001672619 2026-06-11 2026-06-11
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 11, 2026
Enliven Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
Delaware 001-39247 81-1523849 (State or other... (continue reading...)
Form D/A Pro Athlete Community
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form D VA-0226 Fund I, a series
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 424B2 CITIGROUP INC
The information in this preliminary pricing supplement is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities and Exchange Commission. This preliminary pricing supplement and the accompanying product supplement, underlying supplement, prospectus supplement and prospectus are not an offer to sell... (continue reading...)
More SEC Filings
View Older Stories-
Form D EA-0507 Fund I, a series
-
Form SCHEDULE 13G Long Table Growth Corp. Filed by: Linden Capital L.P.
-
Form 424B3 1st FRANKLIN FINANCIAL
-
Form 8-K MAYS J W INC For: Jun 11
-
Form 8-K InspireMD, Inc. For: Jun 11
-
Form D LO-0513 Fund I, a series
-
Form D NonPublic Industrial AI
-
Form 8-K Caribou Biosciences, For: Jun 11
-
Form 6-K Super Group (SGHC) Ltd For: Jun 11
-
Form 8-K Vera Bradley, Inc. For: Jun 11
-
Form 6-K IsoEnergy Ltd. For: Jun 11
-
Form 10-Q MAYS J W INC For: Apr 30
-
Form 424B3 1st FRANKLIN FINANCIAL
-
Form 6-K MINISO Group Holding For: Jun 11
-
Form 8-K Prairie Operating Co. For: Jun 10
-
Form 424B4 RMG ML Sports Holdings
-
Form 6-K QTREX Quantum Ltd. For: Jun 11
-
Form 8-K ATOSSA THERAPEUTICS, For: Jun 10
-
Form 1-U Naqi Logix Inc. For: Jun 11
-
Form 8-K ARROW FINANCIAL CORP For: Jun 09
-
Form D/A Pam AI Mar 2026 a Series
-
Form 6-K NOVARTIS AG For: Jun 11
-
Form 8-K Rafael Holdings, Inc. For: Jun 11
-
Form 4 Vipshop Holdings Ltd For: Jun 09 Filed by: Wang Yuhua
-
Form D YAR Ventures L.P.
-
Form 425 DANA Inc Filed by: Eaton Corp plc
-
Form 425 DANA Inc Filed by: Eaton Corp plc
-
Form 8-K Summit Therapeutics Inc. For: Jun 10
-
Form N-CEN UNIFIED SERIES TRUST For: Mar 31
-
Form S-4/A Exascale Labs Inc. Filed by: D. Boral ARC Acquisition I Corp.
-
Form 144 Fiverr International Filed by: Levy Dadon Esther
-
Form 6-K THOMSON REUTERS CORP For: Jun 11
-
Form DEFA14A Organon & Co.
-
Form 8-K Silence Therapeutics For: Jun 11
-
Form 6-K AURORA CANNABIS INC For: Jun 11
-
Form FWP Swarmer, Inc Filed by: Swarmer, Inc
-
Form 144 Seagate Technology Holdi Filed by: Romano Gianluca
-
Form 8-K Rigetti Computing, Inc. For: Jun 09
-
Form 6-K NOVONIX Ltd For: Jun 11
-
Form 6-K Alithya Group inc For: Mar 31
-
Form 8-K Driven Brands Holdings For: Jun 11
-
Form 4 Matador Resources Co For: Jun 09 Filed by: Stetson Glenn W
-
Form 4 Matador Resources Co For: Jun 09 Filed by: Foran Joseph Wm
-
Form 10-K McGraw Hill, Inc. For: Mar 31
-
Form 8-K Xeris Biopharma Holdings For: Jun 10
-
Form 6-K AC Immune SA For: Jun 11
-
Form 8-K McGraw Hill, Inc. For: Jun 11
-
Form 144 Seagate Technology Holdi Filed by: MOSLEY WILLIAM D
-
Form 6-K Kanzhun Ltd For: Jun 11
-
Form 8-K Climb Bio, Inc. For: Jun 11
